Skip to main content

Tepotinib Hydrochloride

Placeholder slot
 (teh-POH-tih-nib HY-droh-KLOR-ide)

This page contains brief information about tepotinib hydrochloride and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
Tepmetko
FDA Approved
Yes

FDA label information for this drug is available at DailyMed.

Use in Cancer

Tepotinib hydrochloride is approved to treat:

This use is approved under FDA’s Accelerated Approval Program. As a condition of approval, confirmatory trial(s) must show that tepotinib hydrochloride provides a clinical benefit in these patients.

Tepotinib hydrochloride is also being studied in the treatment of other types of cancer.

More About Tepotinib Hydrochloride

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Research Results and Related Resources

Targeted Cancer Therapies

Clinical Trials Accepting Patients

Find Clinical Trials for Tepotinib Hydrochloride - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted:
  • Updated: